[1] Kotani K, Maekawa M, Kanno T, Kondo A, Toda N, Manabe M. Distribution of immunoreactive malondialdehyde-modified low-density lipoprotein in human serum. Biochim Biophys Acta 1994;1215:121–5.
[2] Kitano S, Kanno T, Maekawa M, Sakurabayashi I, Kotani K, Hisatomi H, et al. Improved method for the immunological detection of malondialdehyde-modified low-density lipoproteins in human serum. Anal Chim Acta 2004;509:229–35.
[3] Tanaga K, Bujo H, Inoue M, Mikami K, Kotani K, Takahashi K, et al. Increased circulating malondialdehyde-modified LDL levels in patients with coronary artery diseases and their association with peak sizes of LDL particles. Arterioscler Thromb Vasc Biol 2002;22:662–6.
[4] Shigematsu S, Takahashi N, Hara M, Yoshimatsu H, Saikawa T. Increased incidence of coronary in-stent restenosis in type 2 diabetic patients is related to elevated serum malondialdehyde-modified low-density lipoprotein. Circ J: Off J Japanese Circ Soc 2007;71:1697–702.
[5] Ogawa K, Tanaka T, Nagoshi T, Sekiyama H, Arase S, Minai K, et al. Increase in the oxidised low-density lipoprotein level by smoking and the possible inhibitory effect of statin therapy in patients with cardiovascular disease: a retrospective study. BMJ Open 2015;5 e005455.
[6] Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature 2001;414:813–20.
[7] Hotamisligil GS. Inflammation and metabolic disorders. Nature 2006;444:860–7.
[8] El-Osta A, Brasacchio D, Yao D, Pocai A, Jones PL, Roeder RG, et al. Transient high glucose causes persistent epigenetic changes and altered gene expression during subsequent normoglycemia. J Exp Med 2008;205:2409–17.
[9] Houstis N, Rosen ED, Lander ES. Reactive oxygen species have a causal role in multiple forms of insulin resistance. Nature 2006;440:944–8.
[10] Du XL, Edelstein D, Dimmeler S, Ju Q, Sui C, Brownlee M. Hyperglycemia inhibits endothelial nitric oxide synthase activity by posttranslational modification at the Akt site. J Clin Investig 2001;108:1341–8.
[11] Kugiyama K, Yasue H, Okumura K, Ogawa H, Fujimoto K, Nakao K, et al. Nitric oxide activity is deficient in spasm arteries of patients with coronary spastic angina. Circulation 1996;94:266–71.
[12] Nakayama M, Yasue H, Yoshimura M, Shimasaki Y, Kugiyama K, Ogawa H, et al. T-786–>C mutation in the 5’-flanking region of the endothelial nitric oxide synthase gene is associated with coronary spasm. Circulation 1999;99:2864–70.
[13] Ross R. Atherosclerosis–an inflammatory disease. N Engl J Med 1999;340:115–26.
[14] Gimbrone Jr MA, Garcia-Cardena G. Endothelial cell dysfunction and the pathobiology of atherosclerosis. Circ Res 2016;118:620–36.
[15] Collins SP, Lindsell CJ, Pang PS, Storrow AB, Peacock WF, Levy P, et al. Bayesian adaptive trial design in acute heart failure syndromes: moving beyond the mega trial. Am Heart J 2012;164:138–45.
[16] Kinoshita K, Kawai M, Minai K, Ogawa K, Inoue Y, Yoshimura M. Potent influence of obesity on suppression of plasma B- type natriuretic peptide levels in patients with acute heart failure: an approach using covariance structure analysis. Int J Cardiol 2016;215:283–90.
[17] Modan M, Halkin H, Almog S, Lusky A, Eshkol A, Shefi M, et al. A link between hypertension obesity and glucose intolerance. J Clin Investig 1985;75:809–17.
[18] Dankner R, Chetrit A, Shanik MH, Raz I, Roth J. Basal-state hyperinsulinemia in healthy normoglycemic adults is predictive of type 2 diabetes over a 24-year follow-up: a preliminary report. Diabetes Care 2009;32:1464–6.
[19] Fernandez-Twinn DS, Blackmore HL, Siggens L, Giussani DA, Cross CM, Foo R, et al. The programming of cardiac hypertrophy in the offspring by maternal obesity is associated with hyperinsulinemia, AKT, ERK, and mTOR activation. Endocrinology 2012;153:5961–71.
[20] Fiorentino TV, Prioletta A, Zuo P, Folli F. Hyperglycemia- induced oxidative stress and its role in diabetes mellitus related cardiovascular diseases. Curr Pharm Des 2013;19:5695–703.
[21] Esterbauer H, Schaur RJ, Zollner H. Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radical Biol Med 1991;11:81–128.
[22] Halliwell B. Oxidation of low-density lipoproteins: questions of initiation, propagation, and the effect of antioxidants. Am J Clin Nutrit 1995;61:670s–7s.
論文の公開元へ
